These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 37676604)

  • 1. AI-Driven Enhancements in Drug Screening and Optimization.
    Serghini A; Portelli S; Ascher DB
    Methods Mol Biol; 2024; 2714():269-294. PubMed ID: 37676604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial Intelligence and Quantum Computing as the Next Pharma Disruptors.
    Cova T; Vitorino C; Ferreira M; Nunes S; Rondon-Villarreal P; Pais A
    Methods Mol Biol; 2022; 2390():321-347. PubMed ID: 34731476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial intelligence to deep learning: machine intelligence approach for drug discovery.
    Gupta R; Srivastava D; Sahu M; Tiwari S; Ambasta RK; Kumar P
    Mol Divers; 2021 Aug; 25(3):1315-1360. PubMed ID: 33844136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine learning and deep learning in data-driven decision making of drug discovery and challenges in high-quality data acquisition in the pharmaceutical industry.
    Kumar SA; Ananda Kumar TD; Beeraka NM; Pujar GV; Singh M; Narayana Akshatha HS; Bhagyalalitha M
    Future Med Chem; 2022 Feb; 14(4):245-270. PubMed ID: 34939433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommended Guidelines for Developing, Qualifying, and Implementing Complex In Vitro Models (CIVMs) for Drug Discovery.
    Ekert JE; Deakyne J; Pribul-Allen P; Terry R; Schofield C; Jeong CG; Storey J; Mohamet L; Francis J; Naidoo A; Amador A; Klein JL; Rowan W
    SLAS Discov; 2020 Dec; 25(10):1174-1190. PubMed ID: 32495689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revolutionizing Pharmaceutical Industry: The Radical Impact of Artificial Intelligence and Machine Learning.
    Chhina A; Trehan K; Saini M; Thakur S; Kaur M; Shahtaghi NR; Shivgotra R; Soni B; Modi A; Bakrey H; Jain SK
    Curr Pharm Des; 2023; 29(21):1645-1658. PubMed ID: 37550904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial intelligence and machine learning-aided drug discovery in central nervous system diseases: State-of-the-arts and future directions.
    Vatansever S; Schlessinger A; Wacker D; Kaniskan HÜ; Jin J; Zhou MM; Zhang B
    Med Res Rev; 2021 May; 41(3):1427-1473. PubMed ID: 33295676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial Intelligence (AI) in Drugs and Pharmaceuticals.
    Sahu A; Mishra J; Kushwaha N
    Comb Chem High Throughput Screen; 2022; 25(11):1818-1837. PubMed ID: 34875986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opportunities and Considerations in the Application of Artificial Intelligence to Pharmacokinetic Prediction.
    Wright MR
    Methods Mol Biol; 2022; 2390():461-482. PubMed ID: 34731483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Big Techs and startups in pharmaceutical R&D - A 2020 perspective on artificial intelligence.
    Schuhmacher A; Gatto A; Kuss M; Gassmann O; Hinder M
    Drug Discov Today; 2021 Oct; 26(10):2226-2231. PubMed ID: 33965571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of artificial intelligence to enhance phenotypic drug discovery.
    Malandraki-Miller S; Riley PR
    Drug Discov Today; 2021 Apr; 26(4):887-901. PubMed ID: 33484947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Entering the era of computationally driven drug development.
    Maharao N; Antontsev V; Wright M; Varshney J
    Drug Metab Rev; 2020 May; 52(2):283-298. PubMed ID: 32083960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential applications of artificial intelligence in drug discovery and development.
    Farghali H; Kutinová Canová N; Arora M
    Physiol Res; 2021 Dec; 70(Suppl4):S715-S722. PubMed ID: 35199553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial Intelligence and Machine Learning for Lead-to-Candidate Decision-Making and Beyond.
    McNair D
    Annu Rev Pharmacol Toxicol; 2023 Jan; 63():77-97. PubMed ID: 35679624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artificial intelligence and machine learning approaches for drug design: challenges and opportunities for the pharmaceutical industries.
    Selvaraj C; Chandra I; Singh SK
    Mol Divers; 2022 Jun; 26(3):1893-1913. PubMed ID: 34686947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics.
    Koromina M; Pandi MT; Patrinos GP
    OMICS; 2019 Nov; 23(11):539-548. PubMed ID: 31651216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative strategies in drug development: clinical pharmacological aspects.
    Kuhlmann J
    Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial intelligence in drug design.
    Zhong F; Xing J; Li X; Liu X; Fu Z; Xiong Z; Lu D; Wu X; Zhao J; Tan X; Li F; Luo X; Li Z; Chen K; Zheng M; Jiang H
    Sci China Life Sci; 2018 Oct; 61(10):1191-1204. PubMed ID: 30054833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial intelligence in drug development: present status and future prospects.
    Mak KK; Pichika MR
    Drug Discov Today; 2019 Mar; 24(3):773-780. PubMed ID: 30472429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Success stories of AI in drug discovery - where do things stand?
    Mak KK; Balijepalli MK; Pichika MR
    Expert Opin Drug Discov; 2022 Jan; 17(1):79-92. PubMed ID: 34553659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.